Navigation Links
Sunesis Receives Approval for Listing on The NASDAQ Capital Market
Date:7/30/2009

SOUTH SAN FRANCISCO, Calif., July 30 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS), a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers, today announced that NASDAQ has approved its application to transfer the listing of its common stock from The NASDAQ Global Market to The NASDAQ Capital Market. The transfer will be effective at the opening of the market on August 3, 2009. Sunesis will continue to trade under the symbol "SNSS."

The NASDAQ Capital Market is a continuous trading market that operates in the same manner as The NASDAQ Global Market. All companies listed on The NASDAQ Capital Market must meet certain financial requirements and adhere to NASDAQ's corporate governance standards. Sunesis requested the transfer of its listing based upon the company's compliance with the minimum stockholders' equity requirement and all other applicable criteria for continued listing on The NASDAQ Capital Market, but for the $1.00 minimum bid price requirement, which has been suspended by NASDAQ through August 2, 2009. As a result of the market transfer, Sunesis is no longer subject to delisting from NASDAQ as a result of the previously disclosed stockholders' equity deficiency as of December 31, 2008, but it will need to comply with The NASDAQ Capital Market's continued listing requirements on an ongoing basis.

About Sunesis Pharmaceuticals

Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, voreloxin, in multiple indicat
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
2. Sunesis Pharmaceuticals to Present Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
3. Sunesis Pharmaceuticals to Report Third Quarter 2007 Financial Results
4. Sunesis Pharmaceuticals Appoints Lesley A. Stolz, Ph.D., Vice President, Corporate and Business Development
5. Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration
6. Sunesis Pharmaceuticals to Present Interim Phase 2 Data for SNS-595 at the 39th Annual Meeting on Womens Cancer
7. Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results
8. Sunesis Pharmaceuticals to Report Financial Results for the First Quarter on May 8, 2008
9. Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595)
10. Sunesis Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
11. Sunesis to Present at Upcoming Conferences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN ...nistration (FDA) provided written acknowledgement ...cation (BLA) for PROVENGE® (sipuleucel-T) is ...ription Drug User Fee Act (PDUFA) date of May 1, 2...mended BLA. Dendreon is seeking licensure for PRO...
(Date:11/20/2009)...recently announced that Dr. Dominique Hebrault wil...ss Analytical Technology (PAT) in Green Chemistry ... , (PRWEB) November 20, 20...echnology (PAT) in Green Chemistry and Green Engin...Technology (PAT) case studies will be presented on...
(Date:11/19/2009).... 19 Spherix Incorporate...for diabetes therapy, and a provider of technical ...ment, biotechnology and pharmaceutical companies, ...$6.3 million registered direct placement to instit...n stock and warrants to purchase up to 1,104,348 a...
(Date:11/19/2009)... - Aegera Therapeutics Inc. announced today the do... study of AEG35156, a targeted antisense therapeut...indications. ,, The study, entitled "An Open-La...itor of Apoptosis (XIAP) Antisense AEG35156 Given ...bicin in AML Following Failure of a Single Standar...
Breaking Biology Technology:Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2
...e, Wis. - The Wisconsin Department of Agricultur...ded a $50,000 grant to the University of Wisconsi...gradable plastics made from Wisconsin agricultural...headed by Sarah Gong, assistant professor of mecha...n the state,s plastics industry and encourage tech...
... Wis. - Drawing on the immense popularity of the ...m, American Idol , computer software designers ...g to aspiring pop stars. , , Sony Media Software ,...DVD, and audio production, has signed an agreement...lop two software products based on the show, which...
... Wis . - As any gaming guru will tell you, using t...y a new idea. For the medical profession, however,...bably has never been identified as a revolutionary... , ,Kron, a physician with ties to the entertainme...mpany, Medical Cyberworlds, that might have found ...
Other Biology Technology:UWM receives state funding for plastics research 2American Idol spurs music software 2Doctor using new media to break down barriers 2Doctor using new media to break down barriers 3Doctor using new media to break down barriers 4
(Date:11/19/2009)...ring Harbor, NY A four-year, multi-institutional ...ry (CSHL) scientists culminated today in publicati...Science revealing in unprecedented detail the DNA...s it is commonly called by North American consumer... the most valuable agricultural crop grown in the ...
(Date:11/19/2009)..., WALL, N.J., Nov. 19 B...YI), a leader in wireless public safety and finger...ed that the Special Shareholder Meeting held today...use a quorum was not present. ,, (Logo: http:/... ,, While an impressive 99.3% of the 35 million...
(Date:11/19/2009)... Tenn., Nov. 19, 2009 -- Sustainable farming, init...generations, may also play a role in maintaining a...Department of Energy,s Oak Ridge and Los Alamos na...are exploring the large potential of the earth,s s...that new land-use practices could greatly reduce U...
Breaking Biology News(10 mins):Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3ORNL, Los Alamos pioneer new approach to assist scientists, farmers 2ORNL, Los Alamos pioneer new approach to assist scientists, farmers 3Zucker Hillside Researchers to Receive Large Federal Grant to Test for the Early Treatment of Schizophrenia 52341 1Zucker Hillside Researchers to Receive Large Federal Grant to Test for the Early Treatment of Schizophrenia 52341 2Zucker Hillside Researchers to Receive Large Federal Grant to Test for the Early Treatment of Schizophrenia 52341 3Zucker Hillside Researchers to Receive Large Federal Grant to Test for the Early Treatment of Schizophrenia 52341 4Tobira Therapeutics Inc Announces Phase I Data Demonstrating Pharmacokinetic Properties of TAK 652 for the Treatment of HIV 13130 1Tobira Therapeutics Inc Announces Phase I Data Demonstrating Pharmacokinetic Properties of TAK 652 for the Treatment of HIV 13130 2A drug dispensing contact lens 13129 1A drug dispensing contact lens 13129 2
...ectious diseases run in families because one inher...enerally agree that an individual,s genetic makeup...nfectious disease, new findings from researchers i...ror in a single gene is enough to dramatically alt...tions. , Howard Hughes Medical Institute (HHMI)...
...ts do not haphazardly flail about looking for a ho...plants and identify potential hosts by their emiss...cologists. , "We are interested in how plants resp... insect interactions," says Dr. Consuelo M. De Mor...urprising to see how little was available on how a...
...ference between a lifeless sack of chemicals and a...d, according to Stanford biophysical chemist Steve...ty of California-Davis and Lawrence Livermore Nati...ell membranes with unprecedented resolution-on the...vidual molecules but much smaller than entire cell...
Other Biology News:Inheriting a tendency to brain infection 2Inheriting a tendency to brain infection 3Parasitic plants sniff out hosts 2Parasitic plants sniff out hosts 3With record resolution and sensitivity, tool images how life organizes in a cell membrane 2With record resolution and sensitivity, tool images how life organizes in a cell membrane 3With record resolution and sensitivity, tool images how life organizes in a cell membrane 4With record resolution and sensitivity, tool images how life organizes in a cell membrane 5With record resolution and sensitivity, tool images how life organizes in a cell membrane 6
Goat Anti-ORC2L Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Human WASF2 Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Anti-7H6 Antigen (tight-junction associated protein antigen) Monoclonal Antibody, Unconjugated, Clone 7H6 from Cell Sciences
T7Select Biopanning Kit from Novagen
Biology Products: